Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-04-01
|
| Series: | Data in Brief |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340917300574 |
| _version_ | 1818912930464268288 |
|---|---|
| author | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Dan P. Gaile Alan Forrest Alice C. Ceacareanu |
| author_facet | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Dan P. Gaile Alan Forrest Alice C. Ceacareanu |
| author_sort | Zachary A.P. Wintrob |
| collection | DOAJ |
| description | Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided. |
| first_indexed | 2024-12-19T23:22:25Z |
| format | Article |
| id | doaj.art-7c7aff2916ff4f65806c829649a20419 |
| institution | Directory Open Access Journal |
| issn | 2352-3409 |
| language | English |
| last_indexed | 2024-12-19T23:22:25Z |
| publishDate | 2017-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Data in Brief |
| spelling | doaj.art-7c7aff2916ff4f65806c829649a204192022-12-21T20:01:56ZengElsevierData in Brief2352-34092017-04-0111C45946810.1016/j.dib.2017.02.038Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancerZachary A.P. Wintrob0Jeffrey P. Hammel1George K. Nimako2Dan P. Gaile3Alan Forrest4Alice C. Ceacareanu5State University of New York at Buffalo, Dept. of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesCleveland Clinic, Dept. of Biostatistics and Epidemiology, 9500 Euclid Ave., Cleveland, OH 44195, United StatesState University of New York at Buffalo, Dept. of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United StatesState University of New York at Buffalo, Dept. of Biostatistics, 718 Kimball Tower, Buffalo, NY 14214, United StatesThe UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, Campus Box 7569, Chapel Hill, NC 27599, United StatesRoswell Park Cancer Institute, Dept. of Pharmacy Services, Elm & Carlton Streets, Buffalo, NY 14263, United StatesOral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.http://www.sciencedirect.com/science/article/pii/S2352340917300574Growth factorEGFFGFPDGFHGFTGFVEGFInsulin secretagogueBreast cancerDiabetesCancer outcomesCancer prognosis |
| spellingShingle | Zachary A.P. Wintrob Jeffrey P. Hammel George K. Nimako Dan P. Gaile Alan Forrest Alice C. Ceacareanu Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer Data in Brief Growth factor EGF FGF PDGF HGF TGF VEGF Insulin secretagogue Breast cancer Diabetes Cancer outcomes Cancer prognosis |
| title | Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| title_full | Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| title_fullStr | Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| title_full_unstemmed | Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| title_short | Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| title_sort | circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer |
| topic | Growth factor EGF FGF PDGF HGF TGF VEGF Insulin secretagogue Breast cancer Diabetes Cancer outcomes Cancer prognosis |
| url | http://www.sciencedirect.com/science/article/pii/S2352340917300574 |
| work_keys_str_mv | AT zacharyapwintrob circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer AT jeffreyphammel circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer AT georgeknimako circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer AT danpgaile circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer AT alanforrest circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer AT alicecceacareanu circulatinggrowthfactorsdataassociatedwithinsulinsecretagogueuseinwomenwithincidentbreastcancer |